United States (US) Emetogenic Drugs Market (2025-2031) | Trends, Size & Revenue, Companies, Industry, Share, Segmentation, Forecast, Analysis, Growth, Value, Outlook, Competitive Landscape

Market Forecast By Class (Serotonin Receptor Antagonists (5-HT3 RAS), Neurokinin-1 Receptor Antagonist (NK1 RAS), 5HT3 RA/NK1 RA Combination, Corticosteroids, Olanzapine, Others), By Types of Emesis (Acute, Delayed, Anticipatory, Breakthrough, Refactory, Chronic, Others), By Application (Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, Other), By Drug Type (Branded, Generic), By End user (Hospitals, Specialty Clinics, Others) And Competitive Landscape
Product Code: ETC9965166 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Emetogenic Drugs Market Outlook
  • Market Size of United States (US) Emetogenic Drugs Market, 2024
  • Forecast of United States (US) Emetogenic Drugs Market, 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Revenues & Volume for the Period 2021- 2031
  • United States (US) Emetogenic Drugs Market Trend Evolution
  • United States (US) Emetogenic Drugs Market Drivers and Challenges
  • United States (US) Emetogenic Drugs Price Trends
  • United States (US) Emetogenic Drugs Porter's Five Forces
  • United States (US) Emetogenic Drugs Industry Life Cycle
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Class for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Serotonin Receptor Antagonists (5-HT3 RAS) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Neurokinin-1 Receptor Antagonist (NK1 RAS) for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By 5HT3 RA/NK1 RA Combination for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Corticosteroids for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Olanzapine for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Types of Emesis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Acute for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Delayed for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Anticipatory for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Breakthrough for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Refactory for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Chronic for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Highly Emetogenic Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Moderately Emetogenic Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Low Emetogenic Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Other for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Drug Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Branded for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Generic for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By End user for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Emetogenic Drugs Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Emetogenic Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Class
  • Market Opportunity Assessment By Types of Emesis
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By End user
  • United States (US) Emetogenic Drugs Top Companies Market Share
  • United States (US) Emetogenic Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Emetogenic Drugs Company Profiles
  • United States (US) Emetogenic Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?
6Wresearch actively monitors the United States (US) Emetogenic Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Emetogenic Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Emetogenic Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Emetogenic Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Emetogenic Drugs Market - Industry Life Cycle

3.4 United States (US) Emetogenic Drugs Market - Porter's Five Forces

3.5 United States (US) Emetogenic Drugs Market Revenues & Volume Share, By Class, 2021 & 2031F

3.6 United States (US) Emetogenic Drugs Market Revenues & Volume Share, By Types of Emesis, 2021 & 2031F

3.7 United States (US) Emetogenic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 United States (US) Emetogenic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.9 United States (US) Emetogenic Drugs Market Revenues & Volume Share, By End user, 2021 & 2031F

4 United States (US) Emetogenic Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer and chemotherapy treatments in the US

4.2.2 Growing awareness about the management of chemotherapy-induced nausea and vomiting (CINV)

4.2.3 Technological advancements in drug formulations for better efficacy and patient compliance

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval and market entry

4.3.2 High cost associated with the development and commercialization of emetogenic drugs

4.3.3 Potential side effects and safety concerns associated with the prolonged use of these drugs

5 United States (US) Emetogenic Drugs Market Trends

6 United States (US) Emetogenic Drugs Market, By Types

6.1 United States (US) Emetogenic Drugs Market, By Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Emetogenic Drugs Market Revenues & Volume, By Class, 2021- 2031F

6.1.3 United States (US) Emetogenic Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists (5-HT3 RAS), 2021- 2031F

6.1.4 United States (US) Emetogenic Drugs Market Revenues & Volume, By Neurokinin-1 Receptor Antagonist (NK1 RAS), 2021- 2031F

6.1.5 United States (US) Emetogenic Drugs Market Revenues & Volume, By 5HT3 RA/NK1 RA Combination, 2021- 2031F

6.1.6 United States (US) Emetogenic Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F

6.1.7 United States (US) Emetogenic Drugs Market Revenues & Volume, By Olanzapine, 2021- 2031F

6.1.8 United States (US) Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Emetogenic Drugs Market, By Types of Emesis

6.2.1 Overview and Analysis

6.2.2 United States (US) Emetogenic Drugs Market Revenues & Volume, By Acute, 2021- 2031F

6.2.3 United States (US) Emetogenic Drugs Market Revenues & Volume, By Delayed, 2021- 2031F

6.2.4 United States (US) Emetogenic Drugs Market Revenues & Volume, By Anticipatory, 2021- 2031F

6.2.5 United States (US) Emetogenic Drugs Market Revenues & Volume, By Breakthrough, 2021- 2031F

6.2.6 United States (US) Emetogenic Drugs Market Revenues & Volume, By Refactory, 2021- 2031F

6.2.7 United States (US) Emetogenic Drugs Market Revenues & Volume, By Chronic, 2021- 2031F

6.3 United States (US) Emetogenic Drugs Market, By Application

6.3.1 Overview and Analysis

6.3.2 United States (US) Emetogenic Drugs Market Revenues & Volume, By Highly Emetogenic Chemotherapy, 2021- 2031F

6.3.3 United States (US) Emetogenic Drugs Market Revenues & Volume, By Moderately Emetogenic Chemotherapy, 2021- 2031F

6.3.4 United States (US) Emetogenic Drugs Market Revenues & Volume, By Low Emetogenic Chemotherapy, 2021- 2031F

6.3.5 United States (US) Emetogenic Drugs Market Revenues & Volume, By Other, 2021- 2031F

6.4 United States (US) Emetogenic Drugs Market, By Drug Type

6.4.1 Overview and Analysis

6.4.2 United States (US) Emetogenic Drugs Market Revenues & Volume, By Branded, 2021- 2031F

6.4.3 United States (US) Emetogenic Drugs Market Revenues & Volume, By Generic, 2021- 2031F

6.5 United States (US) Emetogenic Drugs Market, By End user

6.5.1 Overview and Analysis

6.5.2 United States (US) Emetogenic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United States (US) Emetogenic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.5.4 United States (US) Emetogenic Drugs Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Emetogenic Drugs Market Import-Export Trade Statistics

7.1 United States (US) Emetogenic Drugs Market Export to Major Countries

7.2 United States (US) Emetogenic Drugs Market Imports from Major Countries

8 United States (US) Emetogenic Drugs Market Key Performance Indicators

8.1 Patient-reported outcomes related to the reduction of nausea and vomiting during chemotherapy

8.2 Adoption rate of novel drug delivery systems for emetogenic drugs

8.3 Number of clinical trials evaluating the safety and efficacy of new emetogenic drugs

9 United States (US) Emetogenic Drugs Market - Opportunity Assessment

9.1 United States (US) Emetogenic Drugs Market Opportunity Assessment, By Class, 2021 & 2031F

9.2 United States (US) Emetogenic Drugs Market Opportunity Assessment, By Types of Emesis, 2021 & 2031F

9.3 United States (US) Emetogenic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 United States (US) Emetogenic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.5 United States (US) Emetogenic Drugs Market Opportunity Assessment, By End user, 2021 & 2031F

10 United States (US) Emetogenic Drugs Market - Competitive Landscape

10.1 United States (US) Emetogenic Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Emetogenic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Related Reports

Industry Events and Analyst Meet

Smart Home Expo 2025

Smart Home Expo 2025

Industrial Facilities Management Expo 2025

Industrial Facilities Management Expo 2025

4th Edition India Energy Conclave 2025

4th Edition India Energy Conclave 2025

Media Expo 2025

Media Expo 2025

Gas India Expo 2025

Gas India Expo 2025

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
©2025 6Wresearch, All Right Reserved